The same treatment caused IL-2 serum levels boosting (578 pg/ml) compared with untreated tumor-bearing mice that exhibited values of 185, 107, 30, and 52 pg/ml for IL-2, IL-4, IL-10, and IFN-γ, respectively. The gene discussed is IFNG; the disease is neoplasm.